Sabrina Rossi

11PUBLICATIONS
63CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersArtificial life and complex adaptive systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 27, 2026
PIK3CA Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted Patients.

Sabrina Rossi, Arianna Pagliaro, Silvia Masini

|May 11, 2024
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung Cancer.

Sabrina Rossi, Silvia Masini, Giovanna Finocchiaro

|Mar 06, 2024
Response to first-line pembrolizumab in metastatic KRAS-mutated non-small-cell lung cancer.

Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro

|Feb 05, 2024
Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer.

Alessandra Rigamonti, Marika Viatore, Rebecca Polidori

|Dec 23, 2023
The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?

Sabrina Rossi, Arianna Pagliaro, Angelica Michelini

|Jan 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Marco Tagliamento, Alessandra Gennari, Matteo Lambertini

Pageof 2

Frequent Collaborators

2 joint publications

Egesta Lopci

2 joint publications

Silvia Masini

2 joint publications

Vitale Antonio

1 joint publications

Marco Tagliamento